Americans who use cannabis or hold favorable views toward the plant tend to identify themselves politically as Independent rather than as a Democrat or a Republican, according to the results of a Cannalytics consumer research survey published today.
Among respondents, 46 percent defined themselves as Independent. Of this group, over 90 percent consider marijuana policy reform to be among the most important election issues, and more than 75 percent said that they are more motivated to vote this election because of pending cannabis-specific ballot measures.
Voters in nine states will decide on Election Day in favor of statewide ballot measures seeking to legalize either the medical use or the adult use of marijuana.
Cannalytics and its partners, including NORML, provided a 51-point questionnaire to over 5,800 respondents to gauge their opinions on cannabis policy, as well as their own marijuana use. Respondents typically were well educated, most did not smoke tobacco, and 53 percent suggested that they would consume less alcohol if cannabis were legally regulated for adults.
Full results of the 2016 Cannabis Voter Report are available online at: http://www.cannalytics.us/.
More than nine in ten pediatric oncology providers with opinions favor patients’ access to cannabis therapy, according to survey data provided this week at the 2016 annual meeting of the American Society of Clinical Oncology.
Investigators from various US cancer treatment centers surveyed 654 pediatric oncology providers, including physicians and nurses, at three National Cancer Institute-designated cancer centers in Illinois, Massachusetts, and Washington. Over 300 providers (46 percent) completed the survey.
Of those, 92 percent said that they were “willing to help pediatric cancer patients access medical marijuana,” and just over one-third (34 percent) acknowledged that cannabis therapy “is appropriate in the early stages of cancer treatment.”
Thirty percent of respondents reported receiving requests from patients or their families to access medical marijuana therapy at least once per month.
Overall, pediatric oncology providers hold “predominantly favorable attitudes toward medical marijuana use in pediatric cancer patients,” authors concluded.
Previous surveys of physicians and health care providers report similar attitudes. Survey results published in 2013 in the New England Journal of Medicine reported that 76 percent of respondents supported the use of cannabis therapy in the treatment of metastatic breast cancer. A 2014 poll of over 1,500 physicians commissioned by Web MD similarly reported that 82 percent of oncologists believed that marijuana treatment provides legitimate therapeutic benefits.
An abstract of the survey data, “Pediatric oncology providers and use of medical marijuana in children with cancer,” appears online here.
Fifty-six percent of Americans say “Marijuana use should be legal,” according to the results of a nationwide poll commissioned by CBS News. The percentage is the highest ever reported by news agency.
Only 36 percent of respondents said that they opposed legalization.
Seventy-one percent of respondents between the ages of 18 and 34 said that marijuana use ought to be legal, an increase of 10 percent since CBS posed the question last year. Among those age 35 to 64, 57 percent of respondents backed legalization, while only 31 percent of those age 65 or older did so.
Men (59 percent) were more likely than women (54 percent) to support making marijuana use legal. Democrats (63 percent) and Independents (58 percent) were far more likely to support legalization compared to Republicans (44 percent).
In response to a separate polling question, 51 percent of Americans admitted having consumed cannabis, up from 34 percent in 1997.
The poll possesses a margin of error of +/- four percent.
The CBS survey results are similar to those of other recent national polls, such as those by reported by Gallup, CBS, and Pew, finding that a majority of Americans now support ending marijuana prohibition.
Chronic pain patients with legal access to medicinal cannabis significantly decrease their use of opioids, according to data published online ahead of print in The Journal of Pain.
Investigators at the University of Michigan, Ann Arbor conducted a retrospective survey of 244 chronic pain patients. All of the subjects in the survey were qualified under Michigan law to consume medicinal cannabis and frequented an area dispensary to obtain it.
Authors reported that respondents often substituted cannabis for opiates and that many rated marijuana to be more effective.
“Among study participants, medical cannabis use was associated with a 64% decrease in opioid use, decreased number and side effects of medications, and an improved quality of life,” they concluded. “This study suggests that many chronic pain patients are essentially substituting medical cannabis for opioids and other medications for chronic pain treatment, and finding the benefit and side effect profile of cannabis to be greater than these other classes of medications.”
About 40 people die daily from opioid overdoses, according to the US Centers for Disease Control.
Clinical trial data published last month in The Clinical Journal of Pain reported that daily, long-term herbal cannabis treatment is associated with improved pain relief, sleep and quality of life outcomes, as well as reduced opioid use, in patients unresponsive to conventional analgesic therapies.
The results of a 2015 Canadian trial similarly concluded that chronic pain patients who consumed herbal cannabis daily for one-year experienced reduced discomfort and increased quality of life compared to controls, and did not possess an increased risk of serious side effects.
Separate data published in 2014 in The Journal of the American Medical Association determined that states with medical marijuana laws experience far fewer opiate-related deaths than do states that prohibit the plant. Investigators from the RAND Corporation reported similar findings in 2015, concluding, “States permitting medical marijuana dispensaries experience a relative decrease in both opioid addictions and opioid overdose deaths compared to states that do not.” Clinical data published in 2011 in the journal Clinical Pharmacology & Therapeutics previously reported that the administration of vaporized cannabis “safely augments the analgesic effect of opioids.”
An abstract of the University of Michigan study, “Medical cannabis associated with decreased opiate medication use in retrospective cross-sectional survey of chronic pain patients,” appears online here.
A majority of registered Maryland voters believe that cannabis use should be legally regulated in a manner similar to alcohol, according to statewide polling data provided by Gonzalez Research & Marketing Strategies and commission by the Marijuana Policy Project.
Fifty-three percent of respondents said that they favor a change in state law “to allow marijuana to be regulated and taxed similarly to alcohol, for legal use by adults 21 years of age and older.” Forty-three percent of those surveyed opposed legalization.
In 2014, former Gov. Martin O’Malley signed legislation into law decriminalizing marijuana possession offenses involving ten grams or less. Earlier today, lawmakers overrode a 2015 veto to enact legislation decriminalizing the possession of marijuana-related paraphernalia.